Magnetic Resonance Imaging of the Liver in Children 0-2 Months of Age With an Intravenous Injection of Eovist/Primovist Which is a Contrast Agent

PHASE3TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Magnetic Resonance Imaging
Interventions
DRUG

Gadoxetate disodium (Eovist/Primovist, BAY86-4873)

Participants to receive single dose of Eovist/Primovist as a manual injection at a dose of 0.1 milliliter per kilogram (mL/kg) body weight (BW) (0.025 millimole \[mmol\]/kg BW), followed by a flush of at least 5 mL saline (sodium chloride 0.9 percent \[%\] solution) manually.

Trial Locations (9)

10032

New York

11219

Brooklyn

19104

Philadelphia

20010

Washington D.C.

45229

Cincinnati

53792

Madison

94304

Palo Alto

98105

Seattle

90027-6089

Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY